Endowments for Harvard and Princeton have participated in Material Impact’s second fund, which closed at $200m after being oversubscribed.

OUP-backed utility customer data provider Urjanet has added $14.7m to its coffers.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Repare Therapeutics, which is commericalising precision cancer drugs based on research at UofT and NYU, added $33m to its IPO after its shares rose 65% post-offering.

Areas to be targeted by Climate Pledge Fund will include transport, logistics, manufacturing, materials, renewable energy, food and agriculture technology.

Forma Therapeutics, whose investors include Eli Lilly and Novartis, has closed its IPO after seeing its shares double in price.

The home care provider has closed a round led by Optum Ventures and backed by Humana and Echo Health Ventures at approximately $136m.

Experian is exiting the financial data technology provider Finicity in a deal that could reach $985m taking earn-outs into account.

University of Washington’s artificial intelligence-powered customer support spinout AnswerDash has been bought by CloudEngage.

Celgene Switzerland and BMS-backed precision cancer drug developer Repare Therapeutics added $33m to its IPO after its shares rose 65% post-offering.